ClinVar Miner

Submissions for variant NM_001148.6(ANK2):c.10531C>T (p.Leu3511=)

gnomAD frequency: 0.00022  dbSNP: rs148462839
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV001094931 SCV000447227 uncertain significance Cardiac arrhythmia, ankyrin-B-related 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV000857873 SCV000516123 likely benign not provided 2021-10-04 criteria provided, single submitter clinical testing
Invitae RCV000380245 SCV000627608 likely benign Long QT syndrome 2024-01-22 criteria provided, single submitter clinical testing
Ambry Genetics RCV000620985 SCV000738184 likely benign Cardiovascular phenotype 2017-09-27 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV000857873 SCV001154261 likely benign not provided 2022-03-01 criteria provided, single submitter clinical testing ANK2: BP4
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000857873 SCV001477544 likely benign not provided 2020-01-16 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002282123 SCV002572194 benign not specified 2022-08-20 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003950224 SCV004757834 likely benign ANK2-related condition 2019-03-05 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.